You are currently not taking any of our courses.
Educate both your staff and your customers with our different courses!
Start your new reusable contact lens patients in ACUVUE® OASYS with HYDRACLEAR® PLUS contact lenses:
ACUVUETM RevitaLens Multi-Purpose Disinfecting Solution, a great match with ACUVUE® OASYS with HYDRACLEAR® PLUS reusable contact lenses4,5,6 – it’s a tried and tested combination you and your patients can rely on5,6,7 for exceptional disinfection and all-day comfort.4,5,6
8.4 mm base curve/14 mm diameter
8.8 mm base curve/14 mm diameter
Power Ranges
-0.50D to -6.00D (0.25D increments)
-6.50D to -12.00D (0.50D increments)
+0.50D to +6.00D (0.25D increments)
+6.50D to +8.00D (0.50D increments)
Plano lens available for therapeutic use
2-week replacement (for daily wear)
ACUVUE® OASYS with HYDRACLEAR® PLUS provides proven comfort and a legacy of innovation.
ACUVUE® OASYS with HYDRACLEAR® PLUS has an embedded wetting agent throughout the lens matrix. This wetting agent mimics the mucin layer of the tear film and helps keep the tear film stable.2 In this way, ACUVUE® OASYS may help to reduce dryness symptoms caused by staring at digital screens. Wearers using a computer report that ACUVUE® OASYS keeps their eyes feeling moist all day.2,8
In 22 clinical studies posted on www.clinicaltrials.gov ACUVUE® OASYS Family of 2-weekly reusable contact lenses has never been beaten in comfort.§§ When surveyed, 7 out of 10 lens wearers said it is the most comfortable brand of contact lenses they have ever worn, even when using a digital device.1
Packing solution contains boric acid and disodium tetraborate (sodium borate) to control the pH of the solution.
§ Source Euromonitor International Limited; Eyewear 2025 edition; value sales at rsp, all retail channels, 2023 data.
§§ ClinicalTrials.gov is a website maintained by the NIH. The 22 clinical studies evaluated subjective comfort as a primary or secondary endpoint for ACUVUE® OASYS Brand 2-week family contact lenses vs. competitors’ products. Review conducted as of April 30, 2024.
**All ACUVUE® Brand Contact Lenses have Class 1 or Class 2 UV-blocking to help provide protection against transmission of harmful UV radiation to the cornea and into the eye. UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. UV transmission measured with -1.00 lens.
1. JJV Data on File 2018. Material Properties: ACUVUE® OASYS Brand Contact Lenses with HYDRACLEAR PLUS, ACUVUE® OASYS with Transitions Light Intelligent Technology, and other reusable contact lenses.
2. JJV Data on File 2018. Similarities between Mucin and Poly(N-Vinyl Pyrrolidone) (PVP).
3. Berntsen DA, Hickson-Curran SB, Jones LW, et al. Subjective Comfort and Physiology with Modern Contact Lens Care Products. Optom Vis Sci. 2016,93(8):809-819.
4. JJV Data on File 2017. Multi-center 1-month dispensing daily wear study with senofilcon C toric CLs with RevitaLens OcuTec MPDS, worn for 30 days. N=130 habitual soft toric CL wearers in US.
5. JJV Data on File 2016. Multi-center 1-month dispensing daily wear study with comfilcon A toric using RevitaLens OcuTec MPDS. n=95 habitual soft toric contact lens wearers in the US.
6. JJV Data on File 2017. RevitaLens® OcuTec MPDS compatibility and clinical performance with ACUVUE® Brand Contact Lenses (2 week daily wear study with senofilcon A, etafilcon A & galyfilcon A, n=203 habitual soft contact lens wearers; 1-month daily wear study with senofilcon C toric contact lenses, N=130 habitual soft toric contact lens wearers, in-vitro laboratory evaluations with ACUVUE® Brand reusable contact lens materials).
7. JJV Data on File 2012-2015. Laboratory evaluations with RevitaLens OcuTec MPDS and reusable contact lens materials (senofilcon A, senofilcon C, etafilcon A & galyfilcon A).
8. JJV Data on File 2017. A 4-week randomized, masked, controlled, cross-over, dispensing daily wear study with ACUVUE® OASYS vs. ULTRA; n=127 subjects who spent greater than or equal to 8 hours per day using digital devices during the study period.
9. Pall B, Wales M, Roussopoulou E. Eye Care Professional and Contact Lens Wearer Perspectives on Digital Screen Devices. Optom. Vis. Sci. 2014;91:e-abstract 145197.
Important Safety Information: ACUVUE® Contact Lenses are indicated for vision correction. As with any contact lenses, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Contact lenses should not be used in case of eye infections or any other eye conditions, or in case of a systemic disease that may affect the eye. For detailed product information, including contraindications, precautions and adverse reactions, please consult the Instructions for Use available on Johnson & Johnson website www.e-IFU.com.
2024PP15697
Lens Material | senofilcon A |
Technology | HYDRACLEAR® PLUS |
Dk/t (Central)#1 | 147x10-9 |
Water content | 38% |
UV blocker**1 | Class 1 |
Centre thickness at -3.00D (mm) | 0.070 |
Inside-out Mark |
Yes (1-2-3) |
Visibility Tint | Yes |
Package Size | 6 lenses |
Instructions for Use |
Packing solution contains boric acid and disodium tetraborate (sodium borate) to control the pH of the solution.
# Oxygen is only one of several factors related to maintaining overall eye health when wearing contact lenses. Oxygen transmissibility at centre of a -3.00D lens using boundary- corrected, edge-corrected Dk values. Units: (cm/sec) (ml O2/ml x mm Hg) at 35°C. Dk determined via polarographic method.
§ Source Euromonitor International Limited; Eyewear 2024 edition; value sales at rsp, all retail channels, 2022 data; “ACUVUE® family of brands” represents aggregated sales of the following brands: 1-DAY ACUVUE®, ACUVUE®
§§ ClinicalTrials.gov is a website maintained by the NIH. The 22 clinical studies evaluated subjective comfort as a primary or secondary endpoint for ACUVUE® OASYS Brand 2-week family contact lenses vs. competitors’ products. Review conducted as of April 30, 2024..
** All ACUVUE® Brand Contact Lenses have Class 1 or Class 2 UV-blocking to help provide protection against transmission of harmful UV radiation to the cornea and into the eye. UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UV-absorbing goggles or sunglasses because they do not completely cover the eye and surrounding area. UV transmission measured with -1.00 lens.
1. JJV Data on File 2018. Material Properties: ACUVUE® OASYS Brand Contact Lenses with HYDRACLEAR PLUS®, ACUVUE® OASYS with Transitions Light Intelligent Technology, and other reusable contact lenses.
2. JJV Data on File 2018. Similarities between Mucin and Poly(N-Vinyl Pyrrolidone) (PVP).
3. JJV Data on File 2016. 30-day dispensing evaluation, monthly replacement DW study, n = 533 soft silicone hydrogel contact lens wearers in the U.S.
4. JJV Data on File 2017. 30-day dispensing evaluation, monthly replacement DW study, n = 226 soft toric CL wearers in the U.S.
5. Berntsen DA, Hickson-Curran SB, Jones LW, et al. Subjective Comfort and Physiology with Modern Contact Lens Care Products. Optom Vis Sci. 2016,93(8):809-819.
6. JJV Data on File 2017. Multi-center 1-month dispensing daily wear study with senofilcon C toric CLs with RevitaLens OcuTec MPDS, worn for 30 days. N=130 habitual soft toric CL wearers in US.
7. JJV Data on File 2016. Multi-center 1-month dispensing daily wear study with comfilcon A toric using RevitaLens OcuTec MPDS. n=95 habitual soft toric contact lens wearers in the US.
8. JJV Data on File 2017. RevitaLens® OcuTec MPDS compatibility and clinical performance with ACUVUE® Brand Contact Lenses (2 week daily wear study with senofilcon A, etafilcon A & galyfilcon A, n=203 habitual soft contact lens wearers; 1-month daily wear study with senofilcon C toric contact lenses, N=130 habitual soft toric contact lens wearers, in-vitro laboratory evaluations with ACUVUE® Brand reusable contact lens materials).
9. JJV Data on File 2012-2015. Laboratory evaluations with RevitaLens OcuTec MPDS and reusable contact lens materials (senofilcon A, senofilcon C, etafilcon A & galyfilcon A).
10. JJV Data on File 2017. A 4-week randomized, masked, controlled, cross-over, dispensing daily wear study with ACUVUE® OASYS vs. ULTRA; n=127 subjects who spent greater than or equal to 8 hours per day using digital devices during the study period
11. Pall B, Wales M, Roussopoulou E. Eye Care Professional and Contact Lens Wearer Perspectives on Digital Screen Devices. Optom. Vis. Sci. 2014;91:e-abstract 145197.
Important Safety Information: ACUVUE® Contact Lenses are indicated for vision correction. As with any contact lenses, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Contact lenses should not be used in case of eye infections or any other eye conditions, or in case of a systemic disease that may affect the eye. For detailed product information, including contraindications, precautions and adverse reactions, please consult the Instructions for Use available on Johnson & Johnson website www.e-IFU.com.
2024PP15697